Sino Biopharmaceutical (HKG:1177) reported 3.43 billion yuan in profit attributable to owners for the first half, compared with 3.39 billion yuan a year ago, a Wednesday bourse filing showed.
EPS moved to 0.1903 yuan from 0.188 yuan year over year.
For the six months ended June 30, revenue was 19.4 billion yuan, versus 17.6 billion yuan previously, the pharma company said.
The company declared an interim dividend of HK$0.07 per share, payable Sept. 24 to shareholders of record as of Sept. 4. It paid HK$0.05 per share in the year-ago period.